Sign In
Buy GLPG
$27.38
+0.0650 (+0.238%)
At Close: Jun 03, 2026
New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic Arthritis
08:01pm, Friday, 05'th Jun 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced new analyses from two clinical trials evaluating filgotinib, an investigational, oral, selective JAK1 in
Stocks in Europe slip ahead of ECB decision
02:03pm, Thursday, 04'th Jun 2020
European stocks moved off their lowest levels of the day on a slightly more aggressive European Central Bank move than expected.
Galapagos shares rise on Phase 3 studies of arthritis drug it's making with Gilead
07:19am, Thursday, 04'th Jun 2020
Galapagos rose nearly 3% in early Amsterdam trade as Phase 3 studies of drug it's making with Gilead Sciences showed "sustained efficacy and a consistent safety profile" in treating moderately to se
Filgotinib Demonstrates Durable Efficacy and Consistent Safety Profile at 52 Weeks in FINCH 1 and 3 Studies in Rheumatoid Arthritis
05:29am, Thursday, 04'th Jun 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced Week 52 results from the Phase 3 FINCH 1 and FINCH 3 studies of filgotinib, an investigational, oral, se
Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results
03:20pm, Thursday, 21'st May 2020
In a phase 2b/3 study in ulcerative colitis, the drug candidate met its goals, but with results that didn't appear better than those of a potential competitor.
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:01pm, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.) * ADC Therapeutics SA (NYSE: ADCT) (went public M
Gilead, Galapagos Announce Positive Data on Inflammatory Drug
09:17am, Thursday, 21'st May 2020
Gilead (GILD) and Galapagos announce positive data on filgotinib for the treatment of ulcerative colitis.
Gilead and Galapagos Score Positive Topline Results For Ulcerative Colitis Trial
06:37am, Thursday, 21'st May 2020
Gilead Sciences (GILD) and Galapagos NV (GLPG) have announced positive topline results from a Phase 2b/3 trial evaluating the efficacy and safety of the selective JAK1 inhibitor filgotinib in 1,348 pa
Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis
08:03pm, Wednesday, 20'th May 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced positive topline results from SELECTION, a randomized, double-blind, placebo-controlled, Phase 2b/3 tria
H.C. Wainwright Sticks to Their Buy Rating for Galapagos NV
10:52am, Monday, 11'th May 2020
H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Galapagos (NASDAQ:GLPG) NV on Monday, setting a price target of $302, which is approximately 39.09% above the present share pric
Galapagos NV (GLPG) Q1 2020 Earnings Call Transcript
02:00am, Sunday, 10'th May 2020
At this time, I'd like to turn the conference over to Elizabeth Goodwin. Thank you all for joining us today for the audio webcast of Galapagos' first quarter 2020 results. This recorded webcast is a
Best & Worst ADRs - Monday, April 27
04:04pm, Monday, 27'th Apr 2020
The top-ranked sectors are healthcare, technology, consumer goods, and utilities.
Were Hedge Funds Right About HEICO Corporation (HEI)?
07:40pm, Saturday, 25'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
7 stock picks for a volatile market from a manager who ‘finds innovation all over the place’
03:56pm, Saturday, 25'th Apr 2020
The Buffalo Discovery Fund’s Dave Carlsen on seven stock picks, from video-game makers to water-purification companies.
7 Beautiful Biotech Stocks to Buy Here
03:41pm, Friday, 24'th Apr 2020
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
